NASDAQ:PSTX
Delisted

Poseida Therapeutics Stock Signals

etoro logo Buy PSTX
*Your capital is at risk
$9.50
+0 (+0%)
At Close: Apr 04, 2025

Latest Data & Signals Issued

Below are some of the latest signals issued for Poseida Therapeutics, Inc.

General

Signal Type Signal Value Data
Score 0.000 251 days ( -217.73 %
Last Price $9.50 0 %
Performance History
7 Days
$9.50 $9.50
0%
30 Days
$9.50 $9.50
0%
12 Mos
$3.07 $9.50
209.45%

11/18

Active Buy Signals

Specific Signals

Short Term
Net score: 54.73
Signal Type Signal Value Importance Data
High / Low N/A Very Low $9.50 - $9.50
Trend - 3 mos -0.0588 % High Width: 0.631 %
Pred. range - 3 mos $9.49 - $9.55 Low -0.117 % - 0.513 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Jan 07, 2025 - 61 days
RSI Short Pivot Signal Buy Very Low Jan 27, 2025 - 49 days
Short MA 3 mos Buy Low Jan 10, 2025 - 59 days
Long MA 3 mos Buy Medium Feb 21, 2025 - 31 days
Short/Long MA 3 mos Buy Medium Feb 21, 2025 - 31 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 79.92
Signal Type Signal Value Importance Data
Trend - 12 mos 293.05 % Very High Width: 101.27 %
Pred. range - 12 mos $23.75 - $47.81 High 150.05 % - 403.27 %
Short MA 12 mos Buy Very High Jan 31, 2025 - 45 days
Long MA 12 mos Buy Very High Nov 25, 2024 - 89 days
Short/Long MA 12 mos Buy Very High Nov 25, 2024 - 89 days
Pivot Long Sell Low Dec 31, 2024 - 65 days
RSI Long Pivot Signal Buy Low Feb 05, 2025 - 42 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT POSEIDA THERAPEUTICS, INC.
Poseida Therapeutics
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC). It is also developing P-BCMA-ALLO1, which is in Phase I trial to treat patient...
GOLDEN STAR
Ticker Change Signal Date
FCX
$62.63
7.46% Jul 31
MC
$67.08
2.40% Jul 31
ARW
$212.85
6.96% Jul 30
BIIB
$202.19
3.10% Jul 24
F
FERG
$230.67
10.77% Jul 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE